# Edwards Lifesciences to acquire Innovalve Bio Medical for $300M

Edwards Lifesciences exercised an option to buy Innovalve Bio Medical, an Israel-based startup developing transcatheter mitral valve replacement technologies, for about $300 million in cash. The deal is expected to close by end of 2024.

- Type: Acquisition
- Announced: 2024-07-15
- Where: Israel
- Value: $300.0M
- Status: announced
- Products: transcatheter mitral valve replacement technologies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Edwards Lifesciences](https://endata.com/companies/5656.md) (acquirer)
- [Innovalve Bio Medical](https://endata.com/companies/78611.md) (target)

## Sources

- [medtechdive.com](https://www.medtechdive.com/news/edwards-mitral-innovalve-affluent-deals/721359/), 2024-07-15: "Edwards expects to pay about $300 million in cash at the closing of the acquisition, which is forecasted for the end of 2024."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.